Purpose: To identify trends in the utilization of second trimester maternal serum screening, follow-up amniocenteses, and the detection of Down syndrome–affected pregnancies between 1991 and 2003.

Women’s opinion on the maternal serum screening programme offered at one maternity unit in East Northumberland (1991–1992) was evaluated. The responses from 1,774/2,633 women showed a general ...

Maternal serum screening (MSS) is a blood test that is frequently used to screen for open neural tube defects, Down syndrome, and trisomy 18. Although physicians typically suggest MSS to pregnant ...

Screening for aneuploid pregnancies is routinely performed after 15 weeks of gestation and has a sensitivity of approximately 65 percent, with a false positive rate of 5 percent. First-trimester ...

Figure 1. When prenatal testing for T21 began some 20 years ago, it was usually limited to women 35 years or older. Amniocentesis and karyotyping provided diagnostic tests. Today, maternal serum can ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

Researchers provide a comprehensive overview of prenatal screening for fetal aneuploidies, including traditional serum screening, ultrasound imaging, and cell-free DNA testing. A 37-year-old pregnant ...

Prenatal screening for Down syndrome (DS) is still in need of improvement. Perinatal medicine experts have worked hard to find new biomarkers for screening of DS. Dr. Shi he Shao and his ...

New York, July 31, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Prenatal Screening Tests (In Vitro Diagnostics) - Global Market ...

Human cytomegalovirus (CMV) is a common virus found worldwide. When CMV infects fetuses, it can cause serious complications such as hearing difficulties and mental retardation in affected infants. A ...

The objective of Global Prenatal, Maternal & Carrier Diagnostic Market Analysis to 2021 report is to provide an overview of the various technologies being employed for detecting genetic diseases in ...